Neonatal jaundice is a major global health issue that can lead to serious complications and even death if not promptly treated. ABO incompatibility is a common cause of pathological neonatal jaundice, but there are currently no specific tests to predict its severity or progression. This project aims to study the role of exosomes in the diagnosis and treatment of newborn jaundice, focusing on their impact on infants with ABO incompatibility. The study will take place at a reference neonatal intensive care unit, involving 45 infants. Serum and breast milk samples will be collected and analyzed to determine any relationships and possible correlations.
Study Type
OBSERVATIONAL
Enrollment
338
Neonatal serum and maternal exosome profiles will be studied in all groups.
University of Health Sciences Istanbul KSS Training and Research Hospital
Istanbul, Kucukcekmece, Turkey (Türkiye)
Number of the participant who Need for Treatment
Association between the serum and breastmilk exosome and need for treatment due to ABO incompability
Time frame: 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.